Batinic-Haberle, I., Duan, W., Du, L., Huang, Z., Tovmasyan, A., Cao, Z., … Secord, A. A. (2020). MnTnBuOE-2-PyP5+ Ascorbate in the Treatment of Ovarian Cancer. In Free Radical Biology and Medicine (Vol. 159, pp. S51–S51). Elsevier BV. https://doi.org/10.1016/j.freeradbiomed.2020.10.138

Batinic-Haberle, Ines, Weina Duan, Li Du, Zhiqing Huang, Artak Tovmasyan, Zhipeng Cao, Shara Reihani, Ivan Spasojevic, Huaxin Sheng, and Angeles Alvarez Secord. “MnTnBuOE-2-PyP5+ Ascorbate in the Treatment of Ovarian Cancer.” In Free Radical Biology and Medicine, 159:S51–S51. Elsevier BV, 2020. https://doi.org/10.1016/j.freeradbiomed.2020.10.138.

Batinic-Haberle I, Duan W, Du L, Huang Z, Tovmasyan A, Cao Z, et al. MnTnBuOE-2-PyP5+ Ascorbate in the Treatment of Ovarian Cancer. In: Free Radical Biology and Medicine. Elsevier BV; 2020. p. S51–S51.

Batinic-Haberle, Ines, et al. “MnTnBuOE-2-PyP5+ Ascorbate in the Treatment of Ovarian Cancer.” Free Radical Biology and Medicine, vol. 159, Elsevier BV, 2020, pp. S51–S51. Crossref, doi:10.1016/j.freeradbiomed.2020.10.138.

Batinic-Haberle I, Duan W, Du L, Huang Z, Tovmasyan A, Cao Z, Reihani S, Spasojevic I, Sheng H, Secord AA. MnTnBuOE-2-PyP5+ Ascorbate in the Treatment of Ovarian Cancer. Free Radical Biology and Medicine. Elsevier BV; 2020. p. S51–S51.